Skip to main content
Premium Trial:

Request an Annual Quote

NorDiag Completes Merger with Genpoint Subsidiary

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Norwegian sample preparation firm NorDiag today said it has completed its merger with wholly owned subsidiary Genpoint.

The merger was announced in May as a way to reduce costs to both companies. As part of the transaction, all Genpoint employees are being offered employment with NorDiag, which acquired Genpoint in 2007.

The transaction was carried out with accounting and taxation effect from January 2010, NorDiag said in a statement.

Based in Oslo, NorDiag develops tools for the sample preparation of DNA from difficult biological samples such as stool, urine, and sputum. Genpoint, also based in Oslo, develops and markets nucleic acid sample preparation products for use in DNA-based diagnostics.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.